Trial Identifier: | D8664R00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03193060 |
Start Date: | September 2017 |
Primary Completion Date: | December 2019 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China, Beijing | Beijing, China |
China, Guangdong | Guangzhou, Guangdong, China |
China, Guangdong | Huizhou, Guangdong, China |
China, Guangdong | Jiangmen, Guangdong, China |
China, Guangdong | Meizhou, Guangdong, China |
China, Guangdong | Zhuhai, Guangdong, China |
China, He Bei | Shi Jiazhuang, He Bei, China |
China, Hebei | Langfang, Hebei, China |
China, Heilongjiang | Harbin, Heilongjiang, China |
China, Henan | Zhengzhou, Henan, China |
China, Hubei | Wuhan, Hubei, China |
China, Inner Mongolia | Baotou, Inner Mongolia, China |
China, Jiangsu | Nanjing, Jiangsu, China |
China, Ningxia | Yinchuan, Ningxia, China |
China, Shandong | Jinan, Shandong, China |
China, Shandong | Yantai, Shandong, China |
China, Shanghai | Shanghai, China |
China, Shanxi | Xi'an, Shanxi, China |
China, Sichuan | Chengdu, Sichuan, China |
China, Xinjiang | Urumqi, Xinjiang, China |
China, Zhejiang | Hangzhou, Zhejiang, China |
China, Zhejiang | Jiaxing, Zhejiang, China |
China, Zhejiang | Ningbo, Zhejiang, China |